{"brief_title": "Alternate-Day Buprenorphine Administration. Phase I - 3", "brief_summary": "The purpose of this study is to determine if two times a subject's daily maintenance dose will hold for 48 hours without changes in agonist and antagonist effects.", "condition": "Opioid-Related Disorders", "intervention_type": "Drug", "intervention_name": "Buprenorphine", "criteria": "Please contact site for information.", "gender": "All", "minimum_age": "28 Years", "maximum_age": "45 Years", "healthy_volunteers": "No", "id": "NCT00000221.xml"}